News

RenoVō® CASE STUDY: KERATITIS
Written by : Renovo Equine

Case presentation: June 13, 2022: A 12 year-old Gelding Trakehner Dressage Horse presented to Topgun Veterinarian Service, Rock Hill, SC, with a history of generalized keratitis in the right eye. Medical history included corneal haze, subepithelial corneal opacity, Rose Bengal and fluorescein positive, subtle anterior cortical lens opacity, normal vitreous and retina, and no fungal hyphae detected. The eye had been treated for over two years with medications including ¼ cc of triple antibiotic ointment twice daily, ¼ cc of plasma 2-3 times daily, ¼ cc of Cyclosporine 1% ointment twice daily, and several drops of AN-HyPro gel daily with minimal improvement.

 

June 17, 2022: The attending veterinarian at Topgun Veterinary Service, Audrey Turbeville, DVM, implanted 1.5 cc RenoVo® subconjunctively in the right eye at her discretion. At the time of implantation, keratitis was still present and the eye stained positive for Rose Bengal and fluorescein.

 

 

July 7, 2022: 20 days following the RenoVo® administration, the eye improved significantly, was clear and negative for Rose Bengal and fluorescein staining.

 

 

October 13, 2022: Four months following the RenoVo® administration, the eye was clinically normal with no evidence of keratitis.

Other Clinical Studies

What’s the Difference Between RenoVō® and PRGF?

What’s the Difference Between RenoVō® and PRGF?

Equine regenerative medicine is evolving quickly, and with that comes more choices. Two options you may be using or evaluating are PRGF (Plasma Rich in Growth Factors) and RenoVō®, an acellular equine amniotic tissue allograft. While both are used to support tissue,...

See all Clinical Studies